skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia

Journal Article · · Blood; (United States)
OSTI ID:5995347

Of 33 patients who had undergone allogeneic bone marrow transplantation during first complete remission of acute nonlymphocytic leukemia, 21 patients have now been followed in continued complete remission for 6-64 mo (median greater than 18 mo) without maintenance chemotherapy. The median age of the surviving patients is 27 yr. Transplant-related complications occurring throughout the first year after marrow grafting were fatal in 7 patients, and leukemic recurrence led to the death of 5 patients. The actuarial long-term disease-free survival is 60% and the actuarial remission rate is 79%.

Research Organization:
Department of Hematology and BMT, City of Hope National Medical Center, Duarte, CA
OSTI ID:
5995347
Journal Information:
Blood; (United States), Vol. 61:3
Country of Publication:
United States
Language:
English

Similar Records

Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants
Journal Article · Tue Nov 01 00:00:00 EST 1983 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5995347

Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy
Journal Article · Tue Jan 01 00:00:00 EST 1985 · Med. Pediatr. Oncol.; (United States) · OSTI ID:5995347

Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells
Journal Article · Fri Sep 01 00:00:00 EDT 1978 · Blood; (United States) · OSTI ID:5995347